C07C 239/12
Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of
Official title: having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
C07C239/12 (Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of) appears on 28 US grants and 22 published applications in this corpus.
Search patents in C07C- Granted patents
- 28
- Published applications
- 22
- Assignees
- 29
- Inventors
- 111
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 1 |
| 2003 | 2 | 2 |
| 2004 | 0 | 1 |
| 2005 | 2 | 2 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 0 | 3 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 2 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hydrogenation process of oxime derivatives9 Dec 2025US 12,491,503 B2Syngenta Crop Protection AG
- Retinoid derivatives with antitumor activity2 Feb 2021US 10,905,668 B2Biogem S.C. A R.L.
- Compositions of oxygenated amines and quinone methides as antifoulants for vinylic monomers22 Dec 2020US 10,869,444 B2Ecolab USA Inc.
- Xanthine oxidase inhibitors and methods of use28 Feb 2017US 9,580,379 B2Baylor College of Medicine
- Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders28 Feb 2017US 9,580,395 B2Vascular Vision Pharmaceutical Co.
- Enamine n-oxide tools for target identification applications25 Jun 2026US 2026/0176274 A1Dana-Farber Cancer Institute, Inc.
- Novel compounds10 Nov 2022US 2022/0354949 A1XENIOPRO GmbH
- Hydrogenation process of oxime derivatives16 Dec 2021US 2021/0387173 A1Syngenta Crop Protection AG
- Compositions of oxygenated amines and quinone methides as antifoulants for vinylic monomers16 Jan 2020US 2020/0017656 A1Ecolab USA Inc.
- Retinoid derivatives with antitumor activity9 Jan 2020US 2020/0009091 A1Biogem S.C. A R.L.
Most cited
By later US patents
- Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds149US 5,965,434 A1999
- Fatty acid derivatives and pharmaceutical compositions containing same41US 5,618,955 AYissum Research Development Company of the Hebrew University of Jerusalem · 1997
- Color developer containing hydroxylamine antioxidants25US 5,660,974 AEastman Kodak Company · 1997
- Method for producing (hetero)aromatic hydroxylamines20US 6,255,489 B1BASF SE · 2001
- C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists12US 6,444,840 B1The Procter & Gamble Company · 2002